BPTH
Bio-Path Holdings, Inc. · NASDAQ
- Sector Health Technology
- Industry Biotechnology
- Website biopathholdings.com
- Employees(FY) 10
- ISIN US09057N4097
Performance
-23.84%
1W
-29.84%
1M
-75.29%
3M
-80.19%
6M
-76.89%
YTD
-92.77%
1Y
Profile
Bio-Path Holdings, Inc. operates as a clinical and preclinical stage oncology focused RNAi nano particle drug development company in the United States. The company develops products based on DNAbilize, a drug delivery and antisense technology platform that uses P-ethoxy, which is a deoxyribonucleic acid (DNA) backbone modification intended to protect the DNA from destruction. Its lead drug candidate is prexigebersen, which is in Phase II clinical trials for the treatment of acute myeloid leukemia (AML) and myelodysplastic syndrome. It is also developing Liposomal Bcl-2 (BP1002) for the treatment of refractory/relapsed lymphoma and chronic lymphocytic leukemia; Liposomal STAT3 (BP1003) for the treatment of pancreatic cancer, non-small cell lung cancer, and AML; and BP1001-A for the treatment of solid tumors. Bio-Path Holdings, Inc. was founded in 2007 and is based in Bellaire, Texas.
Technical Analysis of BPTH 2024-05-10
Overview:
In analyzing the technical indicators for BPTH over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive assessment of the stock's potential price movement. By examining these key factors, we aim to offer valuable insights and predictions for the next few days.
Trend Anal...
Recent News & Updates
- 2024-05-16 00:12
Q1 2024 Bio Path Holdings Inc Earnings Call(Yahoo Finance)
- 2024-05-15 15:02
- 2024-05-14 22:53
- 2024-05-14 19:19
Bio-Path: Q1 Earnings Snapshot(Yahoo Finance)
- 2024-05-14 19:00
- 2024-05-07 19:00
- 2024-04-19 00:14
- 2024-04-18 22:14
- 2024-04-18 01:57
- 2024-04-17 19:00
- 2024-04-14 19:00
Bio-Path Holdings Expands Global Patent Portfolio(Globenewswire)
- 2024-04-01 19:00
- 2024-03-27 04:43
- 2024-03-09 19:17
- 2024-03-08 09:45
Q4 2023 Bio Path Holdings Inc Earnings Call(Yahoo Finance)
- 2024-03-07 18:00
Bio-Path Holdings Reports Full Year 2023 Financial Results(Globenewswire)
- 2024-02-29 18:00
- 2024-02-20 18:00
Bio-Path Holdings Announces 1-for-20 Reverse Stock Split(Globenewswire)
- 2024-01-09 18:00
- 2023-12-13 18:00
- 2023-11-19 23:54
- 2023-11-14 18:12
Bio-Path: Q3 Earnings Snapshot(Yahoo Finance)
- 2023-11-14 18:00
- 2023-11-07 18:00
- 2023-10-23 19:00
- 2023-09-08 04:01
- 2023-08-30 05:11
- 2023-08-15 10:04
Q2 2023 Bio Path Holdings Inc Earnings Call(Yahoo Finance)
- 2023-08-14 19:06
Bio-Path: Q2 Earnings Snapshot(Yahoo Finance)
- 2023-08-14 19:00
Page 1 of 4
previousnext